IL-1β is a key mediator of the inflammatory response and plays a major role on the pathogenesis of inflammatory bowel disease (IBD), consistent with the finding that IL-1β is up-regulated in IBD patients [48] and IBD colonic macrophages release mature IL-1β on exposure to lipopolysaccharide (LPS) [47]. Here, IL1B is linked to inflammatory bowel disease.